Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

A review of dose-dense temozolomide alone and in combination with bevacizumab in patients with first relapse of glioblastoma.

Johansson F, Ekman S, Blomquist E, Henriksson R, Bergström S, Bergqvist M.

Anticancer Res. 2012 Sep;32(9):4001-6.

PMID:
22993350
[PubMed - indexed for MEDLINE]
2.

Bevacizumab and daily temozolomide for recurrent glioblastoma.

Desjardins A, Reardon DA, Coan A, Marcello J, Herndon JE 2nd, Bailey L, Peters KB, Friedman HS, Vredenburgh JJ.

Cancer. 2012 Mar 1;118(5):1302-12. doi: 10.1002/cncr.26381. Epub 2011 Jul 26.

PMID:
21792866
[PubMed - indexed for MEDLINE]
Free Article
3.

Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme.

Vredenburgh JJ, Desjardins A, Kirkpatrick JP, Reardon DA, Peters KB, Herndon JE 2nd, Marcello J, Bailey L, Threatt S, Sampson J, Friedman A, Friedman HS.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):58-66. doi: 10.1016/j.ijrobp.2010.08.058. Epub 2010 Oct 30.

PMID:
21036490
[PubMed - indexed for MEDLINE]
4.

A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.

Gilbert MR, Gonzalez J, Hunter K, Hess K, Giglio P, Chang E, Puduvalli V, Groves MD, Colman H, Conrad C, Levin V, Woo S, Mahajan A, de Groot J, Yung WK.

Neuro Oncol. 2010 Nov;12(11):1167-72. doi: 10.1093/neuonc/noq100. Epub 2010 Aug 20.

PMID:
20729242
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.

Hainsworth JD, Shih KC, Shepard GC, Tillinghast GW, Brinker BT, Spigel DR.

Clin Adv Hematol Oncol. 2012 Apr;10(4):240-6.

PMID:
22706484
[PubMed - indexed for MEDLINE]
6.

Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme.

Kilickap S, Oztoprak I, Yucel B.

Acta Oncol. 2012 Apr;51(4):544-6. doi: 10.3109/0284186X.2011.644251. Epub 2011 Dec 27. No abstract available.

PMID:
22201408
[PubMed - indexed for MEDLINE]
7.

[Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].

Vauleon E, Mesbah H, Gedouin D, Lecouillard I, Louvel G, Hamlat A, Riffaud L, Carsin B, Quillien V, Audrain O, Lesimple T.

Bull Cancer. 2012 Feb 1;99(2):121-6. doi: 10.1684/bdc.2011.1528. French.

PMID:
22257744
[PubMed - indexed for MEDLINE]
8.

Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model.

Mathieu V, De Nève N, Le Mercier M, Dewelle J, Gaussin JF, Dehoux M, Kiss R, Lefranc F.

Neoplasia. 2008 Dec;10(12):1383-92.

PMID:
19048117
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study.

Butowski N, Chang SM, Lamborn KR, Polley MY, Parvataneni R, Hristova-Kazmierski M, Musib L, Nicol SJ, Thornton DE, Prados MD.

Neuro Oncol. 2010 Jun;12(6):608-13. doi: 10.1093/neuonc/nop070. Epub 2010 Feb 15.

PMID:
20156802
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma.

Narayana A, Gruber D, Kunnakkat S, Golfinos JG, Parker E, Raza S, Zagzag D, Eagan P, Gruber ML.

J Neurosurg. 2012 Feb;116(2):341-5. doi: 10.3171/2011.9.JNS11656. Epub 2011 Oct 28.

PMID:
22035272
[PubMed - indexed for MEDLINE]
11.

Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability.

Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1372-80. doi: 10.1016/j.ijrobp.2007.11.068. Epub 2008 Mar 20.

PMID:
18355978
[PubMed - indexed for MEDLINE]
12.

Recent medical management of glioblastoma.

Johnson DR, Chang SM.

Adv Exp Med Biol. 2012;746:26-40. doi: 10.1007/978-1-4614-3146-6_3. Review.

PMID:
22639157
[PubMed - indexed for MEDLINE]
13.

Treatment of children with glioblastoma with conformal radiation, temozolomide, and bevacizumab as adjuncts to surgical resection.

Friedman GK, Spiller SE, Harrison DK, Fiveash JB, Reddy AT.

J Pediatr Hematol Oncol. 2013 Apr;35(3):e123-6. doi: 10.1097/MPH.0b013e318282cd7f.

PMID:
23425999
[PubMed - indexed for MEDLINE]
14.

Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.

Clarke JL, Iwamoto FM, Sul J, Panageas K, Lassman AB, DeAngelis LM, Hormigo A, Nolan CP, Gavrilovic I, Karimi S, Abrey LE.

J Clin Oncol. 2009 Aug 10;27(23):3861-7. doi: 10.1200/JCO.2008.20.7944. Epub 2009 Jun 8.

PMID:
19506159
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.

Chang SM, Lamborn KR, Malec M, Larson D, Wara W, Sneed P, Rabbitt J, Page M, Nicholas MK, Prados MD.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):353-7.

PMID:
15380566
[PubMed - indexed for MEDLINE]
16.

Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

Brandes AA, Tosoni A, Basso U, Reni M, Valduga F, Monfardini S, Amistà P, Nicolardi L, Sotti G, Ermani M.

J Clin Oncol. 2004 Dec 1;22(23):4779-86. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15570079
[PubMed - indexed for MEDLINE]
Free Article
17.

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Brada M, Hoang-Xuan K, Rampling R, Dietrich PY, Dirix LY, Macdonald D, Heimans JJ, Zonnenberg BA, Bravo-Marques JM, Henriksson R, Stupp R, Yue N, Bruner J, Dugan M, Rao S, Zaknoen S.

Ann Oncol. 2001 Feb;12(2):259-66.

PMID:
11300335
[PubMed - indexed for MEDLINE]
Free Article
18.

Bevacizumab: in previously treated glioblastoma.

Moen MD.

Drugs. 2010;70(2):181-9. doi: 10.2165/11203890-000000000-00000.

PMID:
20108991
[PubMed - indexed for MEDLINE]
19.

Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.

Hainsworth JD, Ervin T, Friedman E, Priego V, Murphy PB, Clark BL, Lamar RE.

Cancer. 2010 Aug 1;116(15):3663-9. doi: 10.1002/cncr.25275.

PMID:
20564147
[PubMed - indexed for MEDLINE]
Free Article
20.

Temozolomide and thalidomide in the treatment of glioblastoma multiforme.

Riva M, Imbesi F, Beghi E, Galli C, Citterio A, Trapani P, Sterzi R, Collice M.

Anticancer Res. 2007 Mar-Apr;27(2):1067-71.

PMID:
17465245
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk